Westlake Chemical Partners LP - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on March 26, 2019, with the report dated March 27, 2019. Westlake Chemical Partners LP (the "Partnership") is a Delaware limited partnership engaged in the chemical industry, with its general partner controlled by Westlake Chemical Corporation ("Westlake").
Key Financial Metrics and Transactions
- OpCo Equity Purchase: The Partnership agreed to purchase an additional 4.50% limited partner interest in Westlake Chemical OpCo LP ("OpCo") for approximately $201.4 million. This transaction increases the Partnership's ownership in OpCo to approximately 22.8% on a fully diluted basis.
- Private Placement: The Partnership agreed to issue and sell 2,940,818 Common Units at $21.40 per unit. This is expected to generate net proceeds of approximately $62.0 million.
- Funding Sources: The OpCo Equity Purchase will be funded by proceeds from the Private Placement and borrowings under the Partnership's senior unsecured revolving credit agreement (the "MLP Revolver").
- Use of Proceeds: OpCo intends to use the proceeds from the equity purchase to repay borrowings under its intercompany debt agreements with Westlake.
Material Changes and Related Party Transactions
The filing details significant related party transactions involving Westlake and its affiliates:
- Ownership Structure: Westlake owns and controls the General Partner and holds 14,122,230 Common Units and incentive distribution rights in the Partnership.
- Private Placement Participants: Purchasers include unrelated institutional investors and an "Affiliated Entity" for the benefit of family members of Messrs. Albert Chao and James Chao, who serve as officers and directors of Westlake and the General Partner.
- Approval Process: The transactions were approved by the Conflicts Committee of the General Partner's Board, which consists entirely of independent directors and engaged independent financial and legal advisors.
Guidance, Risks, and Unusual Items
The filing does not provide updated financial guidance, revenue forecasts, or margin projections. It references the Partnership's 2018 Annual Report (Form 10-K) for details on the MLP Revolver and liquidity resources. The primary risk highlighted is the concentration of control and related party nature of the transactions, which required specific conflict committee review. No unusual items or contingencies beyond the described transactions are noted in this filing.
Key Facts for Investor Verification
- Verify the closing date and final settlement of the $201.4 million OpCo Equity Purchase.
- Confirm the actual net proceeds received from the Private Placement of 2,940,818 Common Units.
- Review the updated capital structure of OpCo following the repayment of intercompany debt.
- Monitor the utilization of the MLP Revolver to fund the equity purchase.
- Check for any subsequent filings regarding the Registration Rights Agreement entered into with the Private Placement investors.